ESOMEPRAZOLE GH esomeprazole (as magnesium trihydrate) 40 mg enteric-coated tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

esomeprazole gh esomeprazole (as magnesium trihydrate) 40 mg enteric-coated tablet blister pack

lupin australia pty limited - esomeprazole magnesium trihydrate, quantity: 44.528 mg (equivalent: esomeprazole, qty 40 mg) - tablet, enteric coated - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); crospovidone; purified water; hypromellose phthalate; purified talc; polysorbate 80; macrogol 6000; povidone; microcrystalline cellulose; iron oxide red; silicon dioxide; pregelatinised maize starch; glyceryl monostearate; light magnesium oxide; hyprolose; macrogol 400; titanium dioxide; hypromellose; maize starch; sucrose - esomeprazole enteric-coated tablet indicated for:,1] gastro-oesophageal reflux disease (gord),- treatment of erosive reflux oesophagitis,- long-term management of patients with healed oesophagitis to prevent relapse,- symptomatic treatment of gastro-oesophageal reflux disease (gord),2] patients requiring nsaid therapy,- short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy.,- healing of gastric ulcers associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy,- prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug nsaid (non-selective and cox-2 selective) therapy in patients at risk.,3] prevention of rebleeding of gastric or duodenal ulcers following treatment with esomeprazole solution administered by intravenous infusion.,4] pathological hypersecretory conditions including zollinger-ellison syndrome and idiopathic hypersecretion,in combination with appropriate antibiotics for:,- healing of duodenal ulcer associated with helicobacter pylori,- eradication of helicobacter pylori in patients with active or healed peptic ulcer

ESOMEPRAZOLE GH esomeprazole (as magnesium trihydrate) 20 mg enteric-coated tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

esomeprazole gh esomeprazole (as magnesium trihydrate) 20 mg enteric-coated tablet blister pack

lupin australia pty limited - esomeprazole magnesium trihydrate, quantity: 22.264 mg (equivalent: esomeprazole, qty 20 mg) - tablet, enteric coated - excipient ingredients: purified talc; iron oxide red; polysorbate 80; glyceryl monostearate; silicon dioxide; methacrylic acid - ethyl acrylate copolymer (1:1); light magnesium oxide; hyprolose; microcrystalline cellulose; hypromellose phthalate; povidone; purified water; crospovidone; macrogol 6000; pregelatinised maize starch; macrogol 400; titanium dioxide; hypromellose; iron oxide yellow; maize starch; sucrose - esomeprazole enteric-coated tablet indicated for:,1] gastro-oesophageal reflux disease (gord),- treatment of erosive reflux oesophagitis,- long-term management of patients with healed oesophagitis to prevent relapse,- symptomatic treatment of gastro-oesophageal reflux disease (gord),2] patients requiring nsaid therapy,- short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy.,- healing of gastric ulcers associated with non-steroidal anti-inflammatory drug nsaid (non-selective and cox-2 selective) therapy,- prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug nsaid (non-selective and cox-2 selective) therapy in patients at risk.,3] prevention of rebleeding of gastric or duodenal ulcers following treatment with esomeprazole solution administered by intravenous infusion.,4] pathological hypersecretory conditions including zollinger-ellison syndrome and idiopathic hypersecretion,in combination with appropriate antibiotics for:,- healing of duodenal ulcer associated with helicobacter pylori,- eradication of helicobacter pylori in patients with active or healed peptic ulcer

Amcofen 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

amcofen 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5.125.0 mg/tablet - milbemycin oxime, combinations

Amcofen 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

amcofen 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 2.5,25 mg/tablet - milbemycin oxime, combinations

Mektix 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

mektix 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5,125 mg/tablet - milbemycin oxime, combinations

Mektix 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

mektix 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 2.5,25 mg/tablet - milbemycin oxime, combinations

Milgusto 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

milgusto 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5/125 mg/tablet - milbemycin oxime

Milgusto 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg Ierland - Engels - HPRA (Health Products Regulatory Authority)

milgusto 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 2.5/25 mg/tablet - milbemycin oxime

LURACOR lurasidone hydrochloride 80 mg film-coated tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

luracor lurasidone hydrochloride 80 mg film-coated tablet blister pack

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: citric acid; pregelatinised maize starch; magnesium stearate; povidone; lactose monohydrate; mannitol; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURACOR lurasidone hydrochloride 80 mg film-coated tablet bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

luracor lurasidone hydrochloride 80 mg film-coated tablet bottle

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: povidone; lactose monohydrate; mannitol; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; citric acid; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).